Panmycin
$ 41,00 – $ 260,00Price range: $ 41,00 through $ 260,00
Parlodel
$ 50,00 – $ 468,00Price range: $ 50,00 through $ 468,00
Pariet
$ 43,00 – $ 144,00Price range: $ 43,00 through $ 144,00
Pariet is a highly effective medication designed to manage various acid-related gastrointestinal conditions. As a potent proton pump inhibitor, it works by significantly reducing the amount of acid produced within the stomach. It is primarily used to provide relief from symptoms of gastroesophageal reflux disease (GERD), including persistent heartburn and acid regurgitation. Additionally, Pariet is indicated for the healing of erosive esophagitis and the treatment of active duodenal ulcers. By maintaining a balanced environment in the digestive tract, this medication helps protect the esophageal lining and ensures long-lasting comfort.
Active substance: Rabeprazole
SKU:
Pariet
Category: Gastrointestinal Tract
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Pariet (rabeprazole sodium) belongs to a class of medications known as proton pump inhibitors (PPIs). It works by suppressing gastric acid secretion, making it an essential treatment for acid-related gastrointestinal conditions. This prescription-only formulation helps manage acid reflux, promotes mucosal healing, and protects the stomach lining from excessive acidity.
Dispensed in accordance with applicable federal and state regulations in the United States, rabeprazole sodium is administered under professional medical supervision. Individual therapeutic response dictates dosage adjustment and treatment duration based on specific clinical evaluations.
| Attribute | Details |
|---|---|
| Drug name | Pariet |
| Active ingredient | Rabeprazole sodium |
| Therapeutic class | Proton Pump Inhibitor (PPI) |
| Dosage form | Delayed-release oral tablet |
| Route of administration | Oral |
| Prescription status | Prescription (Rx) |
Clinical Profile and Usage
How the drug works
Rabeprazole sodium is a substituted benzimidazole proton pump inhibitor. The active constituent acts specifically by inhibiting the gastric H+/K+-ATPase enzyme system located on the secretory surface of the parietal cells in the stomach. This enzyme functions as the proton pump within the parietal cell membrane; therefore, rabeprazole sodium blocks the final step of gastric acid production. This inhibitory effect is dose-dependent and suppresses both basal (resting) gastric acid secretion and stimulated gastric acid secretion, regardless of the stimulus. Following oral administration, rabeprazole accumulates within the acidic environment of the parietal cells, where it is converted to its active sulfenamide form to exert its antisecretory action.
Main uses
Pariet (rabeprazole sodium) is indicated for several acid-mediated gastrointestinal conditions approved by regulatory health authorities. Primary indications include the short-term treatment of symptomatic gastroesophageal reflux disease (GERD), healing of erosive or ulcerative GERD, and maintenance of healing of erosive or ulcerative GERD. Additionally, it is prescribed for the healing and symptomatic relief of active duodenal ulcers and active benign gastric ulcers. In combination with appropriate antibacterial regimens, rabeprazole sodium is indicated for the eradication of Helicobacter pylori to reduce the risk of duodenal ulcer recurrence. It is also indicated for the long-term management of pathological hypersecretory conditions, including Zollinger-Ellison syndrome. Any use outside of these established indications is considered off-label and requires distinct medical evaluation.
Dosing schedule
Dosing of Pariet is determined individually based on the specific condition being treated and patient response. For erosive GERD, the standard adult regimen involves 20 mg taken orally once daily for 4 to 8 weeks. For the maintenance of GERD healing, a daily dose of 20 mg may be continued as directed by a healthcare provider. Active duodenal ulcers typically require 20 mg taken once daily after the morning meal for up to 4 weeks. For Helicobacter pylori eradication, rabeprazole is typically co-administered with clarithromycin and amoxicillin as a triple therapy regimen twice daily for 7 days. Tablets should be swallowed whole with fluid and must not be chewed, crushed, or split, as the enteric coating protects the active drug from premature degradation by stomach acid.
What happens in the body
Following oral administration of Pariet, rabeprazole sodium is presented as an enteric-coated tablet to survive gastric acidity. Absorption begins only after the tablet leaves the stomach and enters the duodenum. Absolute bioavailability is approximately 52% due to first-pass hepatic metabolism. Peak plasma concentrations are typically achieved within 2 to 5 hours following administration. Rabeprazole is highly bound to human plasma proteins, primarily albumin, at approximately 96.3%. The drug is extensively metabolized in the liver via non-enzymatic reduction to a thioether form, alongside metabolic pathways mediated by cytochrome P450 enzymes (CYP2C19 and CYP3A4). Metabolites are primarily eliminated through renal excretion (about 90%), with the remainder excreted via feces. The plasma elimination half-life ranges between 1 and 2 hours, though antisecretory effects persist much longer due to irreversible enzyme binding.
Safety Profile, Interactions, and Guidance
Adverse reactions
Pariet is generally well tolerated, but like all pharmacotherapy, it may cause adverse effects. Frequently reported side effects include headache, diarrhea, abdominal pain, nausea, flatulence, constipation, and dizziness. Less common adverse reactions include rash, dry mouth, myalgia, and peripheral edema. Prolonged therapy with proton pump inhibitors may lead to hypomagnesemia, particularly in patients treated for longer than one year or those taking concurrent digoxin or diuretics. Long-term acid suppression is also associated with an increased risk of Clostridioides difficile-associated diarrhea and an elevated risk of bone fractures (hip, wrist, or spine) at higher doses. Severe skin reactions or acute interstitial nephritis require immediate medical discontinuation.
Important precautions
Symptomatic response to rabeprazole sodium does not preclude the presence of gastric malignancy; appropriate diagnostic evaluation should be conducted prior to initiation if alarm symptoms (such as substantial unintentional weight loss, recurrent vomiting, dysphagia, or hematemesis) are present. Patients receiving high-dose or prolonged proton pump inhibitor therapy should be monitored for bone mineral density changes and serum magnesium levels. Concomitant use of rabeprazole with rilpivirine-containing products is contraindicated due to significant reductions in antiretroviral plasma concentrations. Patients with severe hepatic impairment should be monitored closely due to altered clearance.
What not to combine
Co-administration of Pariet with drugs whose absorption depends on gastric pH can alter systemic exposure. For instance, rabeprazole reduces the absorption of ketoconazole, itraconazole, and iron salts, while potentially increasing the absorption of digoxin. Concomitant administration with high-dose methotrexate may elevate serum methotrexate levels, increasing toxicity risks. Concomitant use with warfarin requires monitoring of International Normalized Ratio (INR) and prothrombin time, as interaction potential exists. Furthermore, CYP2C19 inhibitors or inducers (such as fluvoxamine or rifampin) can alter plasma concentrations of rabeprazole sodium.
Food and alcohol interactions
While food does not significantly alter the overall extent of absorption of rabeprazole, taking the tablet with or before a meal may assist in establishing a routine for daily compliance. High-fat meals may delay peak absorption time, though overall bioavailability remains largely unchanged. Alcohol does not directly interfere with the pharmacokinetic profile of rabeprazole sodium; however, alcohol consumption can irritate the gastric mucosa and stimulate stomach acid production, potentially counteracting the therapeutic benefits of acid-suppressive therapy.
Special populations
Pregnancy: Pariet should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus, as adequate and well-controlled studies in pregnant women are limited. Breastfeeding: It is unknown whether rabeprazole is excreted in human milk; cautious evaluation is required prior to use during lactation. Pediatrics: Safety and effectiveness in pediatric patients have been established for specific conditions such as GERD in older children, but dosing must be strictly guided by a pediatric specialist. Geriatrics: No overall differences in safety or effectiveness have been observed between elderly subjects and younger adult patients, though enhanced sensitivity in some older individuals cannot be ruled out.
If you skip a dose
If a scheduled dose of Pariet is missed, it should be taken as soon as remembered on the same day. However, if it is almost time for the next scheduled dose, the missed dose should be skipped entirely, and the normal dosing schedule resumed. Double doses should never be administered to compensate for a forgotten tablet. Maintaining consistent daily timing enhances therapeutic efficacy in controlling gastric acid levels.
Storage and expiration
Pariet tablets should be stored at controlled room temperature, between 20°C and 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). Protect the medication from moisture, heat, and direct light by keeping the tablets in their original packaging until administration. Do not store in humid environments such as bathrooms. Keep out of reach of children and pets. Properly discard any medication that has passed its expiration date printed on the packaging according to local environmental regulations.
Frequently asked questions
Q: How long does it take for Pariet to reduce stomach acid?
Antisecretory activity begins within 1 hour after oral administration of a 20 mg dose. The maximal effect on gastric acid suppression usually occurs within 2 to 4 hours. Acid inhibition increases with repeated daily dosing, achieving steady-state control after approximately 3 days of therapy.
Q: Can Pariet tablets be split or crushed for easier swallowing?
No, Pariet tablets must be swallowed whole with water. They are formulated with an enteric coating designed to prevent the drug from breaking down in the acidic environment of the stomach. Crushing, chewing, or splitting the tablet destroys this protective barrier, impairing the drug’s effectiveness.
Q: Is it necessary to take Pariet before meals?
While Pariet can be taken with or without food, taking it in the morning before breakfast is frequently recommended for consistency and optimal control of daytime gastric secretion. Always follow the specific instructions provided by the prescribing physician.
Q: What should be done if stomach pain persists despite taking Pariet?
Persistent or worsening symptoms require consultation with a healthcare provider. Acid-suppressive therapy may mask underlying conditions, and an incomplete response may necessitate further diagnostic evaluation or adjustment of the treatment regimen.
Q: Can Pariet cause vitamin deficiencies during long-term use?
Yes, long-term daily use of acid-suppressing agents, including rabeprazole for more than 3 years, can impair the absorption of dietary vitamin B12 (cyanocobalamin) due to hypo- or achlorhydria. Healthcare providers may monitor B12 levels during extended therapy.
This text is for informational purposes only and does not constitute individual medical advice.
In accordance with FDA requirements.
Additional information
| Dosage |
20mg |
|---|---|
| Package |
90 pills ,120 pills ,180 pills ,270 pills ,360 pills |
| Ενεργός Ουσία |
Related products
Biaxin
$ 107,00 – $ 427,00Price range: $ 107,00 through $ 427,00
Active substance: Clarithromycin
More Details
This product has multiple variants. The options may be chosen on the product page
Budez CR
$ 23,00 – $ 108,00Price range: $ 23,00 through $ 108,00
Active substance: Budesonide
More Details
This product has multiple variants. The options may be chosen on the product page
Decadron
$ 12,00 – $ 182,00Price range: $ 12,00 through $ 182,00
Active substance: Dexamethasone
More Details
This product has multiple variants. The options may be chosen on the product page
Ditropan
$ 23,00 – $ 262,00Price range: $ 23,00 through $ 262,00
Active substance: Oxybutynin
More Details
This product has multiple variants. The options may be chosen on the product page
Gasex
$ 40,00 – $ 241,00Price range: $ 40,00 through $ 241,00
Active substance: Gasex
More Details
This product has multiple variants. The options may be chosen on the product page
Liv.52 Syrup
$ 60,00
Active substance: Chicory, The Caper Bush
More Details
This product has multiple variants. The options may be chosen on the product page
Meclizine
$ 47,00 – $ 143,00Price range: $ 47,00 through $ 143,00
Active substance: Meclizine
More Details
This product has multiple variants. The options may be chosen on the product page
Motilium
$ 40,00 – $ 95,00Price range: $ 40,00 through $ 95,00
Active substance: domperidone
More Details
This product has multiple variants. The options may be chosen on the product page
